|
2023 Conference Publication Evaluating kidney fibrosis using in vivo 1h magnetic resonance spectroscopy in patients with chronic kidney disease and live donorsHumphries, Tyrone, Dong, Xin, Watson, Julia, Mountford, Carolyn, Ellis, Robert, Vesey, David, Galloway, Graham, Gobe, Glenda and Francis, Ross (2023). Evaluating kidney fibrosis using in vivo 1h magnetic resonance spectroscopy in patients with chronic kidney disease and live donors. 58th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Christchurch, New Zealand, 4–6 September 2023. Richmond, VIC Australia: John Wiley & Sons. |
|
2023 Conference Publication Changes in energy metabolism in the kidney with tubulointerstitial fibrosis: an ex vivo whole tissue 2d-cosy approachHumphries, Tyrone, Gobe, Glenda, Urquhart, Aaron, Vesey, David, Ellis, Robert, Galloway, Graham and Francis, Ross (2023). Changes in energy metabolism in the kidney with tubulointerstitial fibrosis: an ex vivo whole tissue 2d-cosy approach. 60th ERA Congress, Milan, Italy, 15-18 June 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfad063c_4344 |
|
2022 Conference Publication Identifying biochemical changes in the kidney using nuclear magnetic resonance in an adenine-diet chronic kidney disease mouse modelHumphries, Tyrone, Gobe, Glenda, Urquhart, Aaron, Galloway, Graham, Vesey, David and Francis, Ross (2022). Identifying biochemical changes in the kidney using nuclear magnetic resonance in an adenine-diet chronic kidney disease mouse model. 57th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), 0nline, 17–19 October 2022. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/nep.14099 |
|
2018 Conference Publication PAR-2 does not contribute to tubular damage or renal fibrosis in the obstructed kidneyHan, Y., Ma, F., Ozols, E., Chew, P., Vesey, D., Gobe, G., Morais, C., Lohman, R., Suen, J., Fairlie, D. and Nikolic-Paterson, D. (2018). PAR-2 does not contribute to tubular damage or renal fibrosis in the obstructed kidney. 54th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Sydney, Australia, 8–12 September 2018. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/nep.13441 |
|
2018 Conference Publication End-stage kidney disease following surgical management of kidney cancer in QueenslandEllis, R., Edey, D., Del Vecchio, S., Mcstea, M., Hawley, C., Johnson, D., Vesey, D., Morais, C., Jordan, S., Francis, R., Wood, S. and Gobe, G. (2018). End-stage kidney disease following surgical management of kidney cancer in Queensland. 54th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Sydney, Australia, 8-12 September 2018. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/nep.13466 |
|
2017 Conference Publication Elevated serum creatinine and acute kidney injury following radical tumour nephrectomyEllis, R. J., Del Vecchio, S. J., Ng, K. L., Pascoe, E. M., Hawley, C. M., Johnson, D. W., Dimeski, G., Vesey, D. A., Coombes, J. S., Morais, C., Francis, R. S., Wood, S. T. and Gobe, G. C. (2017). Elevated serum creatinine and acute kidney injury following radical tumour nephrectomy. 53rd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Darwin, NT Australia, 4-6 September 2017. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.13104 |
|
2016 Conference Publication Altered Proximal Small-Intestinal Permeability and Bacterial Translocation in Chronic Liver Disease in Relation to Hepatic Fibrosis and Disease SeverityRaj, Ashok S., Holtmann, Gerald, Fletcher, Linda, Vesey, David A., Hickman, Ingrid J., Shanahan, Erin R., Tran, Cuong D. and Macdonald, Graeme (2016). Altered Proximal Small-Intestinal Permeability and Bacterial Translocation in Chronic Liver Disease in Relation to Hepatic Fibrosis and Disease Severity. 57th Annual Meeting and Residents Fellow Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT) / 52nd Annual Meeting on Digestive Disease Week (DDW) / Meeting of the American-Gastroenterological-Association (AGA), San Diego, CA United States, 21-24 May 2016. Philadelphia, PA United States: Elsevier. doi: 10.1016/S0016-5085(16)33950-6 |
|
2016 Conference Publication Protease activated-receptor-2 induced inflammation and fibrosis is mediated in part through activation of transforming growth factor-beta signallingOwens, E., Iyer, A., Morais, C., Lohman, R., Suen, J., Johnson, D., Nikolic-Paterson, D., Gobe, G., Fairlie, D. and Vesey, D. (2016). Protease activated-receptor-2 induced inflammation and fibrosis is mediated in part through activation of transforming growth factor-beta signalling. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth Western Australia, 17–21 September 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12887 |
|
2016 Conference Publication Kidney function following radical tumour nephrectomy. A comparison of functional outcomes by pre-operative CKD stageEllis, R., Del Vecchio, S., Ng, K., Vesey, D., Francis, R., Wood, S. and Gobe, G. (2016). Kidney function following radical tumour nephrectomy. A comparison of functional outcomes by pre-operative CKD stage. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA, Australia, 17–21 September 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12888 |
|
2016 Conference Publication Inflammation in DialysisDheda, S., Min, H., Van, Eps C., Johnson, D., Vesey, D., Healy, H., Hawley, C. and Fahim, M. (2016). Inflammation in Dialysis. The 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, Western Australia, 17–21 September 2016. Hoboken, NJ United States: Wiley-Blackwell. doi: 10.1111/nep.12887 |
|
2016 Conference Publication Pharmacological Inhibition of Protease-Activated Receptor 2 (Par2) Reduces Crescent Formation in Rat Anti-Gbm DiseaseTesch, G., Han, Y., Vesey, D., Gobe, G., Lohman, R., Suen, J., Fairlie, D. and Nikolic-Paterson, D. (2016). Pharmacological Inhibition of Protease-Activated Receptor 2 (Par2) Reduces Crescent Formation in Rat Anti-Gbm Disease. 15th Asian Pacific Congress of Nephrology (APCN) and 52nd ANZSN ASM, Perth, WA, Australia, 17–21 September 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12887 |
|
2015 Conference Publication Indoxyl sulphate induces hypertrophy and impaired metabolic activity in cultured human proximal tubular cellsEllis, R. J., Small, D. M., Ng, K. L., Vesey, D. A., Vitetta, L., Francis, R., Morais, C. and Gobe, G. C. (2015). Indoxyl sulphate induces hypertrophy and impaired metabolic activity in cultured human proximal tubular cells. 51st Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Canberra, Australia, 7-9 September 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12543 |
|
2015 Conference Publication Small intestinal permeability is elevated in chronic viral hepatitis prior to the development of cirrhosis, and is associated with the degree of fibrosisRaj, A. S., Holtmann, G., Fletcher, L., Bhat, P., Tran, C., Black, M., Nath, K., Jao, W., Vesey, D. and Macdonald, G. A. (2015). Small intestinal permeability is elevated in chronic viral hepatitis prior to the development of cirrhosis, and is associated with the degree of fibrosis. 50th International Liver Congress of the European Association for the Study of the Liver, Vienna, Austria, 22-26 April, 2015. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/S0168-8278(15)30748-0 |
|
2014 Conference Publication Hepatic fibrosis is associated with small intestinal permeability in chronic liver disease due to hepatitis C, hepatitis B and non-alcoholic fatty liver disease, in subjects without ascites. A prospective cohort study using non-invasive techniquesRaj, Ashok, Holtmann, Gerald, Bhat, Purnima, Fletcher, Linda, Tran, Cuong, Vesey, David and Macdonald, Graeme (2014). Hepatic fibrosis is associated with small intestinal permeability in chronic liver disease due to hepatitis C, hepatitis B and non-alcoholic fatty liver disease, in subjects without ascites. A prospective cohort study using non-invasive techniques. Asian Pacific Digestive Week, Bali, Indonesia, 22‐25, 2014. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia . doi: 10.1111/jgh.12766_2 |
|
2014 Conference Publication Mitochondrial targeting of superoxide by Mitoq improves metabolic renal dysfunctionWard, M. S., Flemming, N. B., Gallo, L. A., Fotheringham, A., Gobe, G., Vesey, D. and Forbes, J. M. (2014). Mitochondrial targeting of superoxide by Mitoq improves metabolic renal dysfunction. 50th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne Australia, 25–27 August 2014. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12301 |
|
2014 Conference Publication Decreasing apoptosis repressor with caspase recruitment domain (ARC) is associated with disease progression and drug resistance of renal cell carcinomaNg, K. L., Wood, S. T., Ding, J. C., Jayasuriya, T. S., Vesey, D. A., Gobe, G. C. and Morais, C. (2014). Decreasing apoptosis repressor with caspase recruitment domain (ARC) is associated with disease progression and drug resistance of renal cell carcinoma. 67th Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Brisbane, Australia, Mar 16-19, 2014. West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.12618 |
|
2013 Conference Publication Erythropoietin Delivered for Protection From Acute Kidney Injury May Have Secondary Benefits in Protecting HeartMorais, Christudas, Vesey, David A., Johnson, David W. and Gobe, Glenda C. (2013). Erythropoietin Delivered for Protection From Acute Kidney Injury May Have Secondary Benefits in Protecting Heart. 50th European Renal Association European Dialysis and Transplant Association Congress, Istanbul Turkey, 18-21 May 2013. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gft107 |
|
2013 Conference Publication Curcumin attenuates growth of established renal cell carcinoma through suppression of nuclear factor-kappa BMorais, C., Vesey, D., Johnson, D., Wood, S. and Gobe, G. (2013). Curcumin attenuates growth of established renal cell carcinoma through suppression of nuclear factor-kappa B. 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Brisbane, QLD Australia, 9-11 September 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12121 |
|
2012 Conference Publication Increasing anti-apoptotic nucleolar protein-3 correlates with cancer progression in renal cell carcinomaRajandram, R., Gobe, G., Wang, Z., Vesey, D. A., Johnson, D. W. and Morais, C. (2012). Increasing anti-apoptotic nucleolar protein-3 correlates with cancer progression in renal cell carcinoma. 48th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Auckland, New Zealand, 27 - 29 August 2012. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. |
|
2011 Conference Publication Cadmium Toxicity To Proximal Tubular Epithelium Of The Kidney: Roles Of Inflammation And Mitochondrial DysfunctionCorbier M, Bennett N, Whitbourne L, Roy S, Vesey DA and Gobe G (2011). Cadmium Toxicity To Proximal Tubular Epithelium Of The Kidney: Roles Of Inflammation And Mitochondrial Dysfunction. World Congress of Nephrology, Vancouver BC, Canada, April 8-12. |
